Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma.

James I Geller1, Jeffrey S Dome

  • 1Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.

Cancer
|September 21, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Avoiding Cisplatin-Related Hearing Loss, Including Implementing Sodium Thiosulfate as Otoprotectant Into Daily Pediatric Clinical Practice: Proceedings Based on Evidence and Expert Opinion From the Ototoxicity Taskforce of the SIOP Supportive Care Network.

Ear and hearing·2026
Same author

Integrated Molecular, Genomic, and Clinical Characterization of Pediatric and Adolescent Translocation Renal Cell Carcinoma: A Report from the Children's Oncology Group.

Biomedicines·2026
Same author

Systematic Review: Prognostic Molecular Biomarkers in Wilms Tumors.

JCO precision oncology·2026
Same author

Local application of otoprotective compounds other than sodium thiosulfate to prevent cisplatin-induced hearing loss: a systematic review.

Drug delivery·2026
Same author

Treatment of extracranial rhabdoid tumor with intensive ifosfamide-containing chemotherapy regimens.

Frontiers in oncology·2026
Same author

Estimation of Detailed Cardiac Doses for Pediatric Radiation Therapy Patients in National Wilms Tumor Study.

International journal of radiation oncology, biology, physics·2026
Same journal

Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer.

Cancer·2026
Same journal

Proliferative ecotype determines lethal prognosis and therapeutic benefit in urothelial carcinoma.

Cancer·2026
Same journal

Reply to "Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer".

Cancer·2026
Same journal

Pediatric cancer survival in the United States from 2001 to 2021.

Cancer·2026
Same journal

Updates on intratumoral therapies in melanoma.

Cancer·2026
Same journal

Correction to "Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025".

Cancer·2026
See all related articles

Pediatric renal cell carcinoma (RCC) with lymph node involvement but no distant metastasis shows a favorable prognosis. Children with this condition do not require adjuvant therapy, unlike adult patients.

Area of Science:

  • Pediatric Oncology
  • Renal Cell Carcinoma Research
  • Cancer Prognostics

Background:

  • Local lymph node involvement in adult renal cell carcinoma (RCC) is linked to poor outcomes.
  • The prognostic impact of local lymph node involvement in pediatric RCC remains understudied.

Purpose of the Study:

  • To investigate the prognostic significance of local lymph node involvement in pediatric renal cell carcinoma (RCC).
  • To compare outcomes of pediatric RCC with lymph node involvement to adult data.

Main Methods:

  • Retrospective review of pediatric RCC patients treated at St Jude Children's Research Hospital.
  • Systematic review of existing medical literature on pediatric RCC.

Main Results:

Related Experiment Videos

  • Four pediatric RCC patients with lymph node-positive, distant metastasis-negative disease remained disease-free post-surgery without adjuvant therapy.
  • A literature review of 243 pediatric RCC patients showed a 72.4% survival rate for those with lymph node-positive, distant metastasis-negative disease.
  • Outcomes were similar for pediatric patients receiving no adjuvant therapy versus those receiving it.

    • Conclusions:

    • Pediatric lymph node-positive RCC without distant metastasis has a favorable long-term prognosis, significantly better than adult historical controls.
    • Adjuvant therapy is not recommended for these children due to the favorable prognosis.
    • Further research into the biological differences between adult and pediatric RCC is necessary.